Published in J Virol on July 12, 2017
Herpes Simplex Virus 1, Macrophages, and the Cornea. J Virol (2017) 0.75
Reply to "Herpes Simplex Virus 1, Macrophages, and the Cornea". J Virol (2017) 0.75
Restoring function in exhausted CD8 T cells during chronic viral infection. Nature (2005) 28.04
Alternative activation of macrophages. Nat Rev Immunol (2003) 27.53
Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 26.08
How cells respond to interferons. Annu Rev Biochem (1998) 24.27
The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol (2004) 19.38
Biology of natural killer cells. Adv Immunol (1989) 14.77
Alternative activation of macrophages: mechanism and functions. Immunity (2010) 12.43
Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol (2009) 11.63
Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol (2006) 9.82
Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell (1996) 9.03
Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med (1992) 8.27
Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med (1991) 7.52
Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci (2009) 6.93
A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell (1999) 6.82
Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol (1995) 6.09
Functional macrophage cell lines transformed by Abelson leukemia virus. Cell (1978) 5.76
The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep (2014) 4.97
The isolation and characterization of murine macrophages. Curr Protoc Immunol (2008) 4.86
Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci U S A (2004) 4.84
Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science (1993) 4.80
Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity (2003) 4.49
Three classes of cell surface receptors for alphaherpesvirus entry. Virology (2000) 4.41
Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat Immunol (2008) 4.31
Tissue-resident macrophages. Nat Immunol (2013) 4.09
Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol (2005) 3.67
CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J Exp Med (2000) 3.62
Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science (1996) 3.60
Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity (2009) 3.51
Herpes simplex virus epidemiology and ocular importance. Cornea (2001) 3.14
Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology (1987) 3.11
Immune defence in mice lacking type I and/or type II interferon receptors. Immunol Rev (1995) 2.97
The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency. J Virol (1994) 2.94
Macrophage plasticity in experimental atherosclerosis. PLoS One (2010) 2.75
Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest (1993) 2.52
PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B. Cell (2008) 2.49
Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J Virol (2001) 2.43
Dendritic cells and macrophages are required for Th1 development of CD4+ T cells from alpha beta TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-gamma production is IFN-gamma-dependent. Int Immunol (1993) 2.36
Interleukin-12. J Leukoc Biol (1994) 2.22
Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J Virol (1996) 2.14
On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J Immunol (1997) 2.14
Role of interferon-gamma in immune cell regulation. J Leukoc Biol (1995) 2.10
The corneal stroma is endowed with a significant number of resident dendritic cells. Invest Ophthalmol Vis Sci (2003) 2.05
Identification of a novel macrophage population in the normal mouse corneal stroma. Invest Ophthalmol Vis Sci (2002) 1.99
Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology (2006) 1.96
Classification of herpes simplex virus keratitis and anterior uveitis. Cornea (1999) 1.85
Alternative entry receptors for herpes simplex virus and their roles in disease. Cell Host Microbe (2007) 1.78
Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. Immunol Today (1996) 1.74
Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea. Invest Ophthalmol Vis Sci (1998) 1.74
A novel Ly6C/Ly6G-based strategy to analyze the mouse splenic myeloid compartment. Cytometry A (2011) 1.72
Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J Immunol (2008) 1.67
Correction by CSF-1 of defects in the osteopetrotic op/op mouse suggests local, developmental, and humoral requirements for this growth factor. Exp Hematol (1991) 1.62
Type 1 and type 2 cytokine regulation of macrophage endocytosis: differential activation by IL-4/IL-13 as opposed to IFN-gamma or IL-10. J Immunol (1999) 1.58
Corneal antigen-presenting cells. Chem Immunol Allergy (2007) 1.53
Immunometabolism governs dendritic cell and macrophage function. J Exp Med (2015) 1.41
M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms. J Immunol (2009) 1.39
Macrophage extrinsic antiviral activity during herpes simplex virus infection. J Gen Virol (1980) 1.34
Absence of macrophage inflammatory protein-1alpha prevents the development of blinding herpes stromal keratitis. J Virol (1998) 1.33
Herpes simplex virus isolation in chronic stromal keratitis: human and laboratory studies. Curr Eye Res (1987) 1.28
Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice. J Virol (1994) 1.23
The role of LAT in increased CD8+ T cell exhaustion in trigeminal ganglia of mice latently infected with herpes simplex virus 1. J Virol (2011) 1.18
Proinflammatory functions of IL-2 in herpes simplex virus corneal infection. J Immunol (1997) 1.15
Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection. Invest Ophthalmol Vis Sci (2000) 1.15
Novel Markers to Delineate Murine M1 and M2 Macrophages. PLoS One (2015) 1.13
Both CD4+ and CD8+ T cells are involved in protection against HSV-1 induced corneal scarring. Br J Ophthalmol (2000) 1.12
Expanding the role of 3-O sulfated heparan sulfate in herpes simplex virus type-1 entry. Virology (2009) 1.11
Level of herpes simplex virus type 1 latency correlates with severity of corneal scarring and exhaustion of CD8+ T cells in trigeminal ganglia of latently infected mice. J Virol (2008) 1.06
Macrophage-depletion influences the course of murine HSV-1 keratitis. Curr Eye Res (2000) 1.05
Macrophages and dendritic cells use the cytosolic pathway to rapidly cross-present antigen from live, vaccinia-infected cells. J Immunol (2002) 1.01
Cytokines in autoimmunity: role in induction, regulation, and treatment. J Interferon Cytokine Res (2011) 1.00
A role for the JAK-STAT1 pathway in blocking replication of HSV-1 in dendritic cells and macrophages. Virol J (2009) 0.97
Nitric oxide contributes to host resistance against experimental Taenia crassiceps cysticercosis. Parasitol Res (2007) 0.96
IL-12 influences intrathymic T cell development. J Immunol (1994) 0.94
Prospects for developing an effective vaccine against ocular herpes simplex virus infection. Curr Eye Res (2005) 0.93
Role of dendritic cells in enhancement of herpes simplex virus type 1 latency and reactivation in vaccinated mice. Clin Vaccine Immunol (2008) 0.93
Comparison of adjuvant efficacy of herpes simplex virus type 1 recombinant viruses expressing TH1 and TH2 cytokine genes. J Virol (2003) 0.92
Mechanism of inhibition of HSV-1 replication by tumor necrosis factor and interferon gamma. Virology (1991) 0.92
The role of neutralizing antibody and T-helper subtypes in protection and pathogenesis of vaccinated mice following ocular HSV-1 challenge. Immunology (1998) 0.92
Interferons in autoimmune and inflammatory diseases: regulation and roles. J Interferon Cytokine Res (2011) 0.91
Lymphoid-related CD11c+ CD8alpha+ dendritic cells are involved in enhancing herpes simplex virus type 1 latency. J Virol (2008) 0.90
Interleukin-4 regulates proteoglycan-induced arthritis by specifically suppressing the innate immune response. Arthritis Rheum (2007) 0.90
Macrophages and microglia in HSV-1 infected mouse brain. J Neuroimmunol (1995) 0.89
Improved protection from primary ocular HSV-1 infection and establishment of latency using multigenic DNA vaccines. Invest Ophthalmol Vis Sci (2004) 0.89
Macrophage colony-stimulating factor can modulate immune responses and attract dendritic cells in vivo. Hum Gene Ther (2000) 0.87
Macrophages are important determinants of acute ocular HSV-1 infection in immunized mice. Invest Ophthalmol Vis Sci (2007) 0.86
Use of cytokine immunotherapy to block CNS demyelination induced by a recombinant HSV-1 expressing IL-2. Gene Ther (2011) 0.86
The role of T(H)1 and T(H)2 cytokines in HSV-1-induced corneal scarring. Ocul Immunol Inflamm (2002) 0.86
Effect of macrophage activation on resistance of mouse peritoneal macrophages to infection with herpes simplex virus types 1 and 2. J Gen Virol (1988) 0.84
Enhancement of non-specific resistance to viral infection by muramyldipeptide and its analogs. Antiviral Res (1985) 0.84
The role of macrophages in the pathogenesis of HSV-1 induced chorioretinitis in BALB/c mice. Invest Ophthalmol Vis Sci (1994) 0.83
Interactions between herpesvirus entry mediator (TNFRSF14) and latency-associated transcript during herpes simplex virus 1 latency. J Virol (2013) 0.83
Reduced severity of HSV-1-induced corneal scarring in IL-12-deficient mice. Virus Res (2002) 0.83
Macrophage IL-12p70 signaling prevents HSV-1-induced CNS autoimmunity triggered by autoaggressive CD4+ Tregs. Invest Ophthalmol Vis Sci (2011) 0.82
Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge. J Virol (2005) 0.82
Vaccination with different HSV-1 glycoproteins induces different patterns of ocular cytokine responses following HSV-1 challenge of vaccinated mice. Vaccine (1999) 0.81
Inclusion of CD80 in HSV targets the recombinant virus to PD-L1 on DCs and allows productive infection and robust immune responses. PLoS One (2014) 0.80
Role of CD8+ T cells and lymphoid dendritic cells in protection from ocular herpes simplex virus 1 challenge in immunized mice. J Virol (2014) 0.80
Interleukin-12 and its role in cutaneous sensitization. Res Immunol (1996) 0.79